N5 test Bipolar and Schizophrenia Disorders

http://www.nursingcenter.com/prodev/ce_article.asp?tid=581790
1.
Bipolar disorder is characterized by
a. episodes of mania and depression.
b. delusions and hallucinations.
c. multiple personalities.

2.
Certain patients diagnosed with bipolar disorder were found as infants to have
a. exhibited consistent sleep patterns.
b. never experienced separation anxiety.
c. exhibited extreme fussiness.

3.
Which statement regarding the cause of bipolar disorder is correct?
a. There's no genetic predisposition for the disorder.
b. Chemical changes in the brain can be linked to the disorder.
c. Imaging studies show a growth of cells in certain parts of the brain.

4.
The kindling theory of bipolar disorder states
a. reactions to stimuli decrease over time with each episode.
b. reactions to stimuli escalate over time with each episode.
c. reactions to stimuli stay consistent over time with each episode.

5.
Patients in the manic phase of bipolar disorder may
a. exhibit overtly and inappropriately sexual behaviors.
b. feel fatigued.
c. complain of aches and pains that aren't caused by illness or injury.

6.
Schizophrenia is characterized by
a. personality disorders.
b. manic and depressive episodes.
c. hallucinations and delusions.

7.
Schizophrenia affects
a. more men than women.
b. more women than men.
c. men and women equally.

8.
If a person has too little of the neurotransmitter GABA, he'll exhibit
a. a decreased response to a stimulus.
b. an exaggerated response to a stimulus.
c. a lack of motivation.

9.
Positive symptoms of schizophrenia include
a. delusions.
b. social withdrawal.
c. decreased energy and apathy.

10.
If a patient receiving lithium exhibits blurred vision, twitching, and seizures,
a. divide the dose to prevent gastrointestinal upset.
b. coadminister the lithium with propranolol.
c. stop the lithium immediately.

11.
Lithium levels should be drawn
a. 4 to 6 hours after the last dose.
b. 10 to 12 hours after the last dose.
c. 24 hours after the last dose.

12.
The therapeutic level for valproic acid is
a. 8 mcg/ml to 12 mcg/ml.
b. 0.5 mEq/L to 1.2 mEq/L.
c. 50 mcg/ml to 100 mcg/ml.

13.
Antipsychotics affect the levels of neurotransmitters by
a. decreasing the amount of dopamine.
b. decreasing the amount of melatonin.
c. decreasing the amount of GABA.

14.
Patients receiving anticonvulsants need to have
a. blood urea nitrogen and creatinine levels monitored monthly.
b. liver function tests and complete blood cell counts monitored at least every 6 months.
c. serum sodium levels monitored every 6 months.

15.
A patient exhibiting dystonia
a. has a shuffling gait.
b. has difficulty starting or maintaining movement.
c. has involuntary muscle contractions that cause abnormal movements.

16.
A symptom of neuroleptic malignant syndrome from antipsychotic medications is
a. hypothermia.
b. muscle rigidity.
c. decreased blood pressure.

17.
Instruct patients taking lithium to
a. increase their caffeine intake.
b. watch for weight loss.
c. watch for excessive thirst and urination.

18.
To manage the extrapyramidal symptoms from antipsychotics, your patient may be placed on
a. amantadine.
b. lithium.
c. haloperidol.